These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 9224309

  • 21. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
    Wo JY, Shipley WU, Dahl DM, Coen JJ, Heney NM, Kaufman DS, Zietman AL.
    BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448
    [Abstract] [Full Text] [Related]

  • 22. Treatment delay and prognosis in invasive bladder cancer.
    Liedberg F, Anderson H, Månsson W.
    J Urol; 2005 Nov; 174(5):1777-81; discussion 1781. PubMed ID: 16217282
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ, Clark PE, Lowrance WT, Rumohr JA, Barocas DA, Cookson MS, Smith JA, Chang SS.
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
    Boudreaux KJ, Chang SS, Lowrance WT, Rumohr JA, Barocas DA, Cookson MS, Smith JA, Clark PE.
    Cancer; 2009 Feb 15; 115(4):770-5. PubMed ID: 19152431
    [Abstract] [Full Text] [Related]

  • 31. Outcomes in patients with pathological carcinoma in situ only disease at radical cystectomy.
    Hassan JM, Cookson MS, Smith JA, Johnson DL, Chang SS.
    J Urol; 2004 Sep 15; 172(3):882-4. PubMed ID: 15310989
    [Abstract] [Full Text] [Related]

  • 32. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder.
    May M, Nitzke T, Helke C, Vogler H, Hoschke B.
    Scand J Urol Nephrol; 2004 Sep 15; 38(3):231-5. PubMed ID: 15204377
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Bladder preservation therapy conducted by intra-arterial chemotherapy and radiotherapy for muscle invasive bladder cancer.
    Hashine K, Kusuhara Y, Miura N, Shirato A, Sumiyoshi Y, Kataoka M.
    Jpn J Clin Oncol; 2009 Jun 15; 39(6):381-6. PubMed ID: 19351661
    [Abstract] [Full Text] [Related]

  • 35. Does photodynamic transurethral resection of bladder tumour improve the outcome of initial T1 high-grade bladder cancer? A long-term follow-up of a randomized study.
    Denzinger S, Wieland WF, Otto W, Filbeck T, Knuechel R, Burger M.
    BJU Int; 2008 Mar 15; 101(5):566-9. PubMed ID: 17986289
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Cancer specific outcomes in patients with pT0 disease following radical cystectomy.
    Palapattu GS, Shariat SF, Karakiewicz PI, Bastian PJ, Rogers CG, Amiel G, Lotan Y, Vazina A, Gupta A, Sagalowsky AI, Lerner SP, Schoenberg MP, Bladder Cancer Research Consortium.
    J Urol; 2006 May 15; 175(5):1645-9; discussion 1649. PubMed ID: 16600721
    [Abstract] [Full Text] [Related]

  • 39. [Endoscopic operations in invasive cancer of the urinary bladder].
    Martov AG, Chernyshev IV, Sysoev PA, Gushchin BL, Shapovalov VV, Kozlov VV, Kornienko SI.
    Urologiia; 2005 May 15; (2):35-9. PubMed ID: 15989025
    [Abstract] [Full Text] [Related]

  • 40. Bladder-sparing, combined-modality approach for muscle-invasive bladder cancer: a multi-institutional, long-term experience.
    Perdonà S, Autorino R, Damiano R, De Sio M, Morrica B, Gallo L, Silvestro G, Farella A, De Placido S, Di Lorenzo G.
    Cancer; 2008 Jan 01; 112(1):75-83. PubMed ID: 18008364
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.